IN2012MN02925A - - Google Patents

Info

Publication number
IN2012MN02925A
IN2012MN02925A IN2925MUN2012A IN2012MN02925A IN 2012MN02925 A IN2012MN02925 A IN 2012MN02925A IN 2925MUN2012 A IN2925MUN2012 A IN 2925MUN2012A IN 2012MN02925 A IN2012MN02925 A IN 2012MN02925A
Authority
IN
India
Prior art keywords
prulifloxacin
methyl
oxo
crystalline
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Srinivas Laxminarayan Pathi
Dharmaraj Ramachandra Rao
Rajendra Kankan
Venugopalarao Chinimilli
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN2925MUN2012 priority Critical patent/IN2012MN02925A/en
Publication of IN2012MN02925A publication Critical patent/IN2012MN02925A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IN2925MUN2012 2010-06-30 2011-06-30 IN2012MN02925A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2925MUN2012 IN2012MN02925A (enExample) 2010-06-30 2011-06-30

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1920MU2010 2010-06-30
PCT/GB2011/000982 WO2012001357A1 (en) 2010-06-30 2011-06-30 Crystalline form of prulifloxacin and processes for its preparation
IN2925MUN2012 IN2012MN02925A (enExample) 2010-06-30 2011-06-30

Publications (1)

Publication Number Publication Date
IN2012MN02925A true IN2012MN02925A (enExample) 2015-05-22

Family

ID=44454717

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2925MUN2012 IN2012MN02925A (enExample) 2010-06-30 2011-06-30

Country Status (3)

Country Link
GB (1) GB2498107A (enExample)
IN (1) IN2012MN02925A (enExample)
WO (1) WO2012001357A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102718781B (zh) * 2012-05-08 2015-04-29 四川科伦药物研究有限公司 一种普卢利沙星的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0751579B2 (ja) * 1987-11-07 1995-06-05 日本新薬株式会社 キノリンカルボン酸誘導体
US7612205B2 (en) 2003-04-30 2009-11-03 Nippon Shinyaku Co., Ltd. Crystals of quinolinecarboxylic acid derivative solvate
WO2008059512A1 (en) 2006-11-17 2008-05-22 Hetero Drugs Limited Process for preparation of prulifloxacin using novel intermediates
EP2137194A2 (en) 2007-03-14 2009-12-30 Ranbaxy Laboratories Limited Process for the preparation of crystals of prulifloxacin
WO2008111016A1 (en) 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Process for the preparation of pure prulifloxacin
WO2010084508A2 (en) 2009-01-14 2010-07-29 Elder Pharmaceuticals Ltd. Process for the preparation of type i, type ii and type iii crystalline prulifloxacin

Also Published As

Publication number Publication date
WO2012001357A1 (en) 2012-01-05
GB201301307D0 (en) 2013-03-06
GB2498107A (en) 2013-07-03

Similar Documents

Publication Publication Date Title
GEP201706774B (en) Heterocyclyl compounds
MD20140084A2 (en) New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same
IN2014MN02598A (enExample)
MY198066A (en) Method for the preparation of (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient
IN2014KN00948A (enExample)
WO2011121418A9 (en) 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
PH12012502334A1 (en) Heteroaryl imidazolone derivatives as jak inhibitors
WO2014045162A8 (en) ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS
MX361618B (es) Formulaciones farmacéuticas que comprenden derivados de nitrocatecol y métodos para hacer las mismas.
WO2010092090A3 (en) Novel salts of sitagliptin
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
WO2013004995A8 (en) Pyrimidinone compounds and their use
IN2012DN01292A (enExample)
PH12014501026A1 (en) [1, 2, 3]triazolo[4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists
WO2014062838A3 (en) Pkm2 modulators and methods for their use
MX367772B (es) Derivados de n-(2,3-dihidro-1h-pirrolo[2,3,b]piridin-5-il)-4-quina zolinamina y n-(2,3-dihidro-1h-indol-5-il)-4-quinazolinamina novedosos como inhibidores de perk.
WO2013128379A3 (en) Crystalline polymorphic forms of linagliptin
WO2011050054A3 (en) Coumarin compounds as receptor modulators with therapeutic utility
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
EA201291014A1 (ru) Трициклическое индазольное соединение, способ его получения и содержащая его фармацевтическая композиция
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
SA112330457B1 (ar) مشتقات فينيل- ايزواوكسازول وعملية تحضيرها
MX2013012773A (es) Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas.
IN2012MN02925A (enExample)